Mastocytosis
Copyright policy )Mastocytosis
Mastocytosis is a rare disease caused by excessive production of mast cells. Clinical presentation is variable, often based on the type of mastocytosis, but in all types of mastocytosis there seems to be an increase in the risk of anaphylaxis. Systemic mastocytosis is diagnosed based on bone marrow biopsy. Treatment is variable based on the type of mastocytosis, but trigger avoidance and anaphylaxis treatment are mainstays. There are no therapies that change the natural course of mastocytosis. For cutaneous mastocytosis, treatment is conservative and aimed at symptom relief.
- Penn State Milton S. Hershey Medical Center United States
Mastocytosis, Cutaneous, Primary Health Care, Biopsy, Blood Cell Count, Proto-Oncogene Proteins c-kit, Mastocytosis, Systemic, Mutation, Quality of Life, Humans, Tryptases, Mast Cells, Anaphylaxis, Blood Chemical Analysis
Mastocytosis, Cutaneous, Primary Health Care, Biopsy, Blood Cell Count, Proto-Oncogene Proteins c-kit, Mastocytosis, Systemic, Mutation, Quality of Life, Humans, Tryptases, Mast Cells, Anaphylaxis, Blood Chemical Analysis
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).21 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!